PhysioMimix® User Group Meeting
October 17, 2024, marked a milestone for CN Bio as we hosted our inaugural virtual conference and User Group Meeting (UGM).
Designed specifically for our customers, partners, collaborators, and those looking for practical insights into Organ-on-a-chip (OOC) adoption, the event showcased the transformative power of OOC in drug development and research.
Our real-world customers shared their success stories and how OOC technology has impacted their research workflows, while our internal experts delved into the latest developments in our PhysioMimix® OOC range of microphysiological systems (MPS) and solutions.
If you missed our live sessions or you’re looking to revisit the discussions, the UGM presentations offer you valuable information to help you make informed decisions, wherever you are on your MPS/OOC journey.
Proceedings
1. A warm welcome from Deepak Singh
Our VP of Sales & Marketing opens proceedings
2. Opening remarks from Tomasz Kostrzewski
Our Chief Scientific Officer walks through what to expect
3. Whats new at CN Bio
Watch talks from CN Bio Scientists
Dr. Audrey Dubourg (Product Manager), Dr. Emily Richardson (Lead Scientist – Toxicology) and Dr. Yassen Abbas (Lead Scientist – ADME)
4. Keynote speech from Prof. Linda Griffith
New tools for creating “Physiomimetic” models of chronic inflammatory diseases
Prof. Linda Griffith. School of Engineering Professor of Teaching Innovation in Biological Engineering. Massachusetts Institute of Technology
5. Efficacy focus with Claire Caygill
Organ-on-a-chip models to study SARS-CoV-2 infection
Dr. Claire Caygill. Post-Doctoral Research Associate at Liverpool School of Tropical Medicine
PhysioMimix allows you to create complex and physiologically relevant models that accurately express the disease phenotype.
6. Safety toxicology focus from Dr. Déborah Lenart
New Alternative Method for predictive genotoxicity using Micro Physiological System
Dr. Déborah Lenart. Research Scientist, Charles River Laboratories
PhysioMimix organ-on-a-chip models recreate in vivo physiology and function in vitro. They provide a human-specific understanding of potential drug toxicity in healthy and diseased organ models.
7. ADME focus with Amélie Moreau
Organ-on-a-chip added value on ADME issues
Amélie Moreau, PhD. ADME Senior Scientist, Servier R&D Institute
PhysioMimix models are highly metabolically competent, with expression of a full range of cytochrome p450s and transporters.
8. Panel discussion
9. Closing remarks from Dr. Paul Brooks
Our Chief Executive Officer draws an end to UGM24
Dr. Paul Brooks, Chief Executive Officer